Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Adhesion (functional) | = 10 % | In vitro inhibition of 38-beta7 (alpha4-beta7) cell adhesion to mucosal addressin cell adhesion molecule-1. | ChEMBL. | 14667228 |
Adhesion (functional) | = 10 % | In vitro inhibition of Jurkat cell (alpha4-beta1) cell adhesion to vascular cell adhesion molecule-1. | ChEMBL. | 14667228 |
Adhesion (functional) | = 10 % | In vitro inhibition of Jurkat cell (alpha4-beta1) cell adhesion to vascular cell adhesion molecule-1. | ChEMBL. | 14667228 |
IC50 (binding) | = 3.1 uM | In vitro inhibition of RPMI 8866 cell adhesion to human MAdCAM-1 IgG chimera. | ChEMBL. | 9873398 |
IC50 (functional) | = 280 uM | Inhibition of alpha4-beta7 interaction to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) was determined | ChEMBL. | 14667228 |
IC50 (functional) | = 280 uM | Inhibition of alpha4-beta7 interaction to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) was determined | ChEMBL. | 14667228 |
IC50 (binding) | = 465 uM | Inhibition of alpha4-beta7/MAdCAM interactions | ChEMBL. | 11472212 |
IC50 (binding) | = 465 uM | Inhibition of alpha4-beta7/MAdCAM interactions | ChEMBL. | 11472212 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
3 literature references were collected for this gene.